3D Mapping and PVC ablation
Just a few years ago, interventional treatment of ventricular arrhythmias was limited to the implantation of defibrillators. This is a therapy that can save lives, but for many patients, it impairs quality of life due to frequent electrical shocks and sometimes even prolongs suffering. Increasingly, ablation of ventricular arrhythmias can help in these cases, either as a standalone treatment or in combination with a defibrillator.
Our experience in recent years shows that even for complex forms of ablation therapy, outpatient procedures are now possible. With careful treatment planning—using state-of-the-art three-dimensional mapping techniques, new catheter designs, and innovative treatment concepts such as substrate modification and Purkinje modulation—we can significantly increase the long-term effectiveness of this therapy while minimizing the complication rate.
VIVO Mapping System
Fig.: Using AI, the origin of the arrhythmia is identified based on the surface ECG and an external 3D image. This enables a more effective procedure, as it can be planned and performed with even greater precision.
With the VIVO system, we have Switzerland’s first noninvasive mapping system, which can predict the source of a ventricular arrhythmia with the highest precision (95%) even before the actual invasive procedure. For the first time, this enables detailed procedure planning for the appropriate access route, the optimal form of anesthesia, and the selection of the catheters to be used. This new, highly effective method drastically reduces the often lengthy examination time.
